-
1 Comment
Beijing Chunlizhengda Medical Instruments Co., Ltd is currently in a long term downtrend where the price is trading 13.4% below its 200 day moving average.
From a valuation standpoint, the stock is 94.7% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 6.0.
Beijing Chunlizhengda Medical Instruments Co., Ltd's total revenue sank by 15.3% to $407M since the same quarter in the previous year.
Its net income has dropped by 8.4% to $117M since the same quarter in the previous year.
Finally, its free cash flow grew by 146.3% to $12M since the same quarter in the previous year.
Based on the above factors, Beijing Chunlizhengda Medical Instruments Co., Ltd gets an overall score of 2/5.
| Exchange | HK |
|---|---|
| CurrencyCode | HKD |
| ISIN | CNE100001TP1 |
| Sector | Healthcare |
| Industry | Medical Devices |
| Market Cap | 4B |
|---|---|
| PE Ratio | 11.2 |
| Target Price | 20.5127 |
| Dividend Yield | 3.9% |
| Beta | -0.24 |
Beijing Chunlizhengda Medical Instruments Co., Ltd., together with its subsidiaries, engages in the research, development, production, and sale of surgical implants, instruments, and related products in the People's Republic of China and internationally. The company offers orthopedic medical devices and tissue repair products, including spine, trauma, joint, sports medicine, and bone repair material implants; surgical instrumentation products; platelet-rich plasma preparation kits; and closed wound negative pressure drainage kits. It also provides surgical robots; joint, spinal, sports medicine, trauma, oral care, and endoscopic products; orthopedic power products; and platelet-rich plasma preparation system products, as well as alloy materials and surgical powering equipment. The company exports its products to approximately 68 countries. The company was formerly known as Chunli Limited and changed its name to Beijing Chunlizhengda Medical Instruments Co., Ltd. in September 2010. Beijing Chunlizhengda Medical Instruments Co., Ltd. was incorporated in 1998 and is headquartered in Beijing, China.
Learn MoreHere's how to backtest a trading strategy or backtest a portfolio for 1858.HK using our backtest tool. PyInvesting provides the backtesting software for you to backtest your investment strategy. Our backtest software is written using Python code and allows you to backtest stock, backtest etf, backtest options, backtest crypto and backtest forex online. Our backtesting Python framework is highly robust and gives you a realistic simulation of how your strategy would have performed in the past using backtest data.
© PyInvesting 2026
